拓新药业：拟对仅三生物增资1000万元 仅三生物实现了高纯度麦角硫因的制备

Core Viewpoint - Toxin Pharmaceutical (301089.SZ) plans to invest 10 million yuan in Jiangsu Jiansan Biotechnology Co., Ltd. (referred to as "Jiansan Biotechnology") to acquire a 1.75% stake in the company, which has successfully developed high-purity ergothioneine [1] Group 1 - Toxin Pharmaceutical will use its own funds for the investment of 10 million yuan [1] - After the investment, Toxin Pharmaceutical will directly hold 1.75% of Jiansan Biotechnology's equity [1] - Jiansan Biotechnology has achieved the production of high-purity ergothioneine, with main products including ergothioneine skincare products, oral capsules, and eye wash solutions [1]